The presence of AF cell populations that share features with pluripotent stem cells has been suggested based on published evidence on the expression of pluripotency markers, such as Oct-4 [15] and Nanog [17], and the hematopoietic and embryonic stem cell marker c-Kit [21,22]. The gene discussed is NANOG; the disease is atrial fibrillation.